189 related articles for article (PubMed ID: 37714434)
1. Surface modification strategies in translocating nano-vesicles across different barriers and the role of bio-vesicles in improving anticancer therapy.
Tiwari P; Yadav K; Shukla RP; Gautam S; Marwaha D; Sharma M; Mishra PR
J Control Release; 2023 Nov; 363():290-348. PubMed ID: 37714434
[TBL] [Abstract][Full Text] [Related]
2. Bioinspired soft nanovesicles for site-selective cancer imaging and targeted therapies.
Prasad R; Conde J
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2022 Jul; 14(4):e1792. PubMed ID: 35318815
[TBL] [Abstract][Full Text] [Related]
3. Recent advances in dual-ligand targeted nanocarriers for cancer therapy.
Khan N; Ruchika ; Dhritlahre RK; Saneja A
Drug Discov Today; 2022 Aug; 27(8):2288-2299. PubMed ID: 35439614
[TBL] [Abstract][Full Text] [Related]
4. Physicochemical characterization of pH-responsive and fusogenic self-assembled non-phospholipid vesicles for a potential multiple targeting therapy.
Di Francesco M; Celia C; Primavera R; D'Avanzo N; Locatelli M; Fresta M; Cilurzo F; Ventura CA; Paolino D; Di Marzio L
Int J Pharm; 2017 Aug; 528(1-2):18-32. PubMed ID: 28559215
[TBL] [Abstract][Full Text] [Related]
5. Bacterial protoplast-derived nanovesicles for tumor targeted delivery of chemotherapeutics.
Kim OY; Dinh NT; Park HT; Choi SJ; Hong K; Gho YS
Biomaterials; 2017 Jan; 113():68-79. PubMed ID: 27810643
[TBL] [Abstract][Full Text] [Related]
6. Peptide-Conjugated Nano Delivery Systems for Therapy and Diagnosis of Cancer.
Gaurav I; Wang X; Thakur A; Iyaswamy A; Thakur S; Chen X; Kumar G; Li M; Yang Z
Pharmaceutics; 2021 Sep; 13(9):. PubMed ID: 34575511
[TBL] [Abstract][Full Text] [Related]
7. Towards clinical translation of ligand-functionalized liposomes in targeted cancer therapy: Challenges and opportunities.
Belfiore L; Saunders DN; Ranson M; Thurecht KJ; Storm G; Vine KL
J Control Release; 2018 May; 277():1-13. PubMed ID: 29501721
[TBL] [Abstract][Full Text] [Related]
8. Extracellular vesicle mimics made from iPS cell-derived mesenchymal stem cells improve the treatment of metastatic prostate cancer.
Zhao Q; Hai B; Kelly J; Wu S; Liu F
Stem Cell Res Ther; 2021 Jan; 12(1):29. PubMed ID: 33413659
[TBL] [Abstract][Full Text] [Related]
9. Targeted anticancer therapy: overexpressed receptors and nanotechnology.
Akhtar MJ; Ahamed M; Alhadlaq HA; Alrokayan SA; Kumar S
Clin Chim Acta; 2014 Sep; 436():78-92. PubMed ID: 24836529
[TBL] [Abstract][Full Text] [Related]
10. Extracellular Vesicles as Drug Delivery Vehicles to the Central Nervous System.
Shahjin F; Chand S; Yelamanchili SV
J Neuroimmune Pharmacol; 2020 Sep; 15(3):443-458. PubMed ID: 31485884
[TBL] [Abstract][Full Text] [Related]
11. Application of lipid nanovesicle drug delivery system in cancer immunotherapy.
Ding Y; Wang L; Li H; Miao F; Zhang Z; Hu C; Yu W; Tang Q; Shao G
J Nanobiotechnology; 2022 May; 20(1):214. PubMed ID: 35524277
[TBL] [Abstract][Full Text] [Related]
12. Effective Cancer Management: Inimitable Role of Phytochemical Based Nano- Formulations.
Upaganlawar A; Polshettiwar S; Raut S; Tagalpallewar A; Pande V
Curr Drug Metab; 2022; 23(11):869-881. PubMed ID: 36065928
[TBL] [Abstract][Full Text] [Related]
13. The significance of transferrin receptors in oncology: the development of functional nano-based drug delivery systems.
Tortorella S; Karagiannis TC
Curr Drug Deliv; 2014; 11(4):427-43. PubMed ID: 24387131
[TBL] [Abstract][Full Text] [Related]
14. Recent advances in Bio-conjugated nanocarriers for crossing the Blood-Brain Barrier in (pre-)clinical studies with an emphasis on vesicles.
Poustforoosh A; Nematollahi MH; Hashemipour H; Pardakhty A
J Control Release; 2022 Mar; 343():777-797. PubMed ID: 35183653
[TBL] [Abstract][Full Text] [Related]
15. Biomimetic camouflage delivery strategies for cancer therapy.
Asrorov AM; Gu Z; Li F; Liu L; Huang Y
Nanoscale; 2021 May; 13(19):8693-8706. PubMed ID: 33949576
[TBL] [Abstract][Full Text] [Related]
16. Extracellularly activated nanocarriers: a new paradigm of tumor targeted drug delivery.
Gullotti E; Yeo Y
Mol Pharm; 2009; 6(4):1041-51. PubMed ID: 19366234
[TBL] [Abstract][Full Text] [Related]
17. Extracellular Vesicle (EV) biohybrid systems for cancer therapy: Recent advances and future perspectives.
Ou YH; Liang J; Czarny B; Wacker MG; Yu V; Wang JW; Pastorin G
Semin Cancer Biol; 2021 Sep; 74():45-61. PubMed ID: 33609664
[TBL] [Abstract][Full Text] [Related]
18. Modulation of tissue tropism and biological activity of exosomes and other extracellular vesicles: New nanotools for cancer treatment.
Kooijmans SAA; Schiffelers RM; Zarovni N; Vago R
Pharmacol Res; 2016 Sep; 111():487-500. PubMed ID: 27394168
[TBL] [Abstract][Full Text] [Related]
19. Research Progress and Prospects for Polymeric Nanovesicles in Anticancer Drug Delivery.
Li D; Zhang X; Chen X; Li W
Front Bioeng Biotechnol; 2022; 10():850366. PubMed ID: 35223804
[TBL] [Abstract][Full Text] [Related]
20. Modification of Extracellular Vesicle Surfaces: An Approach for Targeted Drug Delivery.
Mohammadi AH; Ghazvinian Z; Bagheri F; Harada M; Baghaei K
BioDrugs; 2023 May; 37(3):353-374. PubMed ID: 37093521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
